Efforts to boost European science and technology have taken on a new, geopolitical tone. What are these new policies? How do they affect global R&D? And will they help or hinder progress in Europe – and beyond?
A special Science|Business news report, with guest opinions, explains it all – for companies, universities, and other research organisations across the globe
After years of debate, research assessment reform has become an urgent priority for policy makers and science organisations alike, both in Europe and beyond. But what are the most effective ways forward? How can all key stakeholders contribute to shaping a new system?
Innovative collection and use of health data will play a vital role in Europe’s future approach to medicines evaluation and regulation. This report explores what the EU can learn from Denmark, one of the world’s leaders in health data systems and strategies.
Sponsored by the Science|Business Future-Proofing Medicines initiative
The invasion of Ukraine has prompted a wave of measures to isolate Russia’s scientific establishment. As geopolitical tensions mount, we must seek global agreement on how researchers can continue to operate, without aiding an aggressor or hampering science.
New research infrastructures (RIs) are needed in Europe to maintain and propel its leadership in science and technology for decades to come. But how can new RIs attract adequate investment? How can their socio-economic and scientific impacts best be assessed?
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.